Therefore, IBD, specific genotypes (MLH1, MSH2, EPCAM), and advancing age were found to be independent risk factors for neoplasia, indicating that patients with LS who have these risk factors might benefit from more intensive surveillance [24]. Here, MLH1 is linked to inflammatory bowel disease.